uniQure Offers Preclinical Data On AMT-130 In Huntington's Disease, Showed Single Intraparenchymal Administration Of AMT-130 In Striatum Resulted In Dose-Dependent, Sustained Reduction Of mHTT In Both Deep Structures Of Brain